Clinical Trials
509 articles
Participating in clinical trials can give you access to the latest treatments for pancreatic cancer.
New Study Targets Specific BRAF Mutation
One type of BRAF mutation may provide a target for treatment in pancreatic cancer patients, explains Dr. Michael Pishvaian.
Five Promising Researchers Leading the Charge in Treatment Advancements
Meet the five promising researchers supported by Let’s Win at the 2023 AACR Special Conference on Research: Pancreatic Cancer.
Study Reveals Molecular Differences in Young-Onset Pancreatic Cancer
There has been a notable increase in cases of young onset pancreatic cancer. Dr. Jashodeep Datta and team are exploring why this is happening.
New Liquid Biopsy Shows Promise for Early Detection
Dr. Ajay Goel has a new approach to a liquid biopsy early detection test for pancreatic cancer. So far, the results are very impressive.
Pancreatic Cancer and Drug Interactions: What You Need to Know
Pharmacist Trevor Christ emphasizes the importance of sharing your medication list with your medical team and pharmacist.
Decoding the Differences between At-Home and Medical Genetic Testing
Genetic counselors Jill Stopfer and Heather Hampel explain the differences between at-home and medical genetic testing, including precision and knowledge.
My Eight-Year Un-Celebration of Surviving Pancreatic Cancer
William Ramshaw shares his thoughts and advice for those in treatment, on reaching the eight-year pancreatic cancer survivor mark.
Alternating Protocols to Attack Pancreatic Cancer
Working with his oncologist, Dr. Mark Fishman decided to follow non-standard alternating protocols to treat his pancreatic cancer.
Chemotherapy Makes Tumor Removal Possible
After failed surgery to remove her cancer, Anne Seagren underwent months of chemotherapy. This made a second attempt at surgery possible.
A New Treatment Leads to a Whipple Procedure
After his pancreatic cancer diagnosis, Guy Davidson looked for the most advanced treatment that would allow him to qualify for a Whipple procedure.
Listen to Your Body
When Roxanne Waling discovered she had pancreatic cancer she underwent genetic testing. She found she was a BRCA2 carrier, which influenced her post-treatment decisions about her health.
The Relatively New Procedure of Irreversible Electroporation Has Given Me Time
When chemotherapy and radiation stopped working, Leslie Wineberg was glad to qualify for irreversible electroporation (IRE).
A Longer Plan with Treatment Options
Susan Riddle had chemotherapy and radiation before she qualified for NanoKnife treatment, all to control her pancreatic cancer.
Molecular Sequencing Leads to Customized Treatment
When Florida resident Doron Broman was diagnosed with stage IV pancreatic cancer, his decision to get treated in Boston gave him access a PARP inhibitor for maintenance.
A Second Opinion Changes the Pancreatic Cancer Game Plan
Gregg Wittman’s doctors diagnosed him with stage IV pancreatic cancer, but could never get a good biopsy; a second opinion figured out the reason.